Oliver Kluth Selected Research

Proteins (Proteins, Gene)

1/2021	Lipocalin 13 enhances insulin secretion but is dispensable for systemic metabolic control.
1/2008	High-fat, carbohydrate-free diet markedly aggravates obesity but prevents beta-cell loss and diabetes in the obese, diabetes-susceptible db/db strain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oliver Kluth Research Topics

Disease

2	Obesity 01/2021 - 01/2008
2	Weight Loss (Weight Reduction) 03/2015 - 01/2008
1	Hypersensitivity (Allergy) 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Diabetes Mellitus 04/2016
1	Hyperphagia (Overeating) 03/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2014
1	Hypertension (High Blood Pressure) 08/2014
1	Polydipsia 01/2008
1	Type 2 Diabetes Mellitus (MODY) 01/2008
1	Morbid Obesity 01/2008

Drug/Important Bio-Agent (IBA)

2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 03/2015
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2008
2	CarbohydratesIBA 03/2015 - 01/2008
1	LipocalinsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2015
1	Uric Acid (Urate)IBA 08/2014
1	Xanthine OxidaseIBA 08/2014
1	urate transporterIBA 08/2014
1	Allopurinol (Remid)FDA LinkGeneric 08/2014
1	purineIBA 08/2014
1	polyureaIBA 01/2008
1	Blood Glucose (Blood Sugar)IBA 01/2008
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 01/2008
1	Dietary Fats (Dietary Fat)IBA 01/2008
1	Insulin (Novolin)FDA Link 01/2008

Therapy/Procedure

2	Therapeutics 01/2021 - 04/2016